Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.
Kircik LH, Alonso-Llamazares J, Bhatia N, Bukhalo M, Devani AR, Draelos ZD, DuBois J, Gooderham MJ, Kempers SE, Lain E, Lee M, Moore A, Murrell DF, Papp KA, Pariser DM, Sinclair R, Zirwas M, Burnett P, Higham RC, Krupa D, Berk DR.
Kircik LH, et al. Among authors: papp ka.
Br J Dermatol. 2023 Sep 15;189(4):392-399. doi: 10.1093/bjd/ljad182.
Br J Dermatol. 2023.
PMID: 37279795
Clinical Trial.